Covid vaccine news: SII's Covovax approved as heterologous booster dose for adults

DCGI has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults.

Covid vaccine news: SII's Covovax approved as heterologous booster dose for adults
DCGI has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults.